Hims & Hers Health (HIMS) Other Non-Current Assets (2020 - 2026)
Hims & Hers Health (HIMS) posted Other Non-Current Assets of $47.6 million for Q1 2026, up 60.46% sequentially from $29.7 million in Q4 2025, and up 2352.37% YoY from $1.9 million in Q1 2025.
Hims & Hers Health (HIMS) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Other Non-Current Assets for 7 years, with the latest figure at $47.6 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 2352.37% year-over-year to $47.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.6 million (up 2352.37% YoY) and the FY2025 annual result came in at $29.7 million, up 3367.29% from the prior year.
- Other Non-Current Assets grew to $47.6 million in Q1 2026 per HIMS's latest filing, from $29.7 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $47.6 million in Q1 2026 and troughed at $856000.0 in Q1 2022.
- A 5-year average of $5.6 million and a median of $856000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets changed 0.0% in 2022, then surged 3367.29% in 2025.
- Over 5 years, Other Non-Current Assets stood at $856000.0 in 2022, then changed by 0.0% to $856000.0 in 2023, then changed by 0.0% to $856000.0 in 2024, then soared by 3367.29% to $29.7 million in 2025, then jumped by 60.46% to $47.6 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $47.6 million, $29.7 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 13.00 Mn |
| 10 | Hims & Hers Health | 7.49 Bn | 6.65 Bn | 480.80 Mn | 78.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 78.31 Mn |
| Mar 31, 2026 | 47.63 Mn |
| Dec 31, 2025 | 29.68 Mn |
| Sep 30, 2025 | 3.88 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Dec 31, 2024 | 856,000.00 |
| Sep 30, 2024 | 856,000.00 |
| Jun 30, 2024 | 856,000.00 |
| Mar 31, 2024 | 856,000.00 |
| Dec 31, 2023 | 856,000.00 |
| Sep 30, 2023 | 856,000.00 |
| Jun 30, 2023 | 856,000.00 |
| Mar 31, 2023 | 856,000.00 |
| Dec 31, 2022 | 856,000.00 |
| Sep 30, 2022 | 856,000.00 |
| Jun 30, 2022 | 856,000.00 |
| Mar 31, 2022 | 856,000.00 |
| Dec 31, 2021 | 856,000.00 |
| Sep 30, 2021 | 856,000.00 |